Wayne Holman, Ridgeback Capital Like Sangamo Biosciences

Wayne Holman, Ridgeback Capital: Wayne Holman’s hedge fund Ridgeback Capital Management recently disclosed the purchasing of some 3.6 million shares of Sangamo Biosciences, Inc. (NASDAQ:SGMO), a filing with the SEC revealed. In this way, Ridgeback Capital Management initiated a position in the company by acquiring 5.9% of its shares, with the value of the stake amounting to almost $38.8 million.

Disclosure: none